EVA Therapeutics, Inc. products

In critically ill patients with respiratory failure, mechanical ventilation and extracorporeal membrane oxygenation are used as standard treatments to provide vital oxygenation. However, in general, their use requires advanced medical resources and highly invasive procedures, potentially making the some of the patients contraindicated. Thus, developing another supportive oxygenation approach is urgently needed to help countless patients under respiratory distressed conditions, now much more become evident due to recent coronavirus pandemic.